Ethinylestradiol/ferrous fumarate/norethindrone - Allergan

Drug Profile

Ethinylestradiol/ferrous fumarate/norethindrone - Allergan

Alternative Names: Ethinylestradiol/ferrous fumarate/norethindrone acetate - Allergan; Taytulla

Latest Information Update: 25 Nov 2016

Price : $50

At a glance

  • Originator Allergan
  • Class Alkylated estrogenic steroids; Antianaemics; Hormonal contraceptives; Hormonal replacements; Norpregnatrienes; Norpregnenes; Oral contraceptives; Small molecules
  • Mechanism of Action Estrogen receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Pregnancy

Most Recent Events

  • 10 Nov 2016 Launched for Pregnancy (Prevention) in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top